Mental Fatigue Healthy Volunteers
Conditions
Interventions
A randomized, double-blind, placebo-controlled crossover clinical trial with 12 participants per group, for a total of 36 participants randomly assigned to three groups: Group 1, which will receive a
Group 2, which will receive 2 g of taurine
and Group 3, which will receive 3 g of taurine. Each participant will undergo 6 collection sessions, consisting of three placebo collections and three supplementation collections, with a one-week inte
instead, they will be recorded in specific spreadsheets for each data collection session. Immediately after the training mission, participants will be asked to retake the tests assessing perceived fat
Sponsors
Universidade do Estado do Rio de Janeiro
Universidade do Estado do Rio de Janeiro
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Military personnel over the age of 18 of either gender who are in full physical and mental capacity; rotary-wing aviation or maritime patrol crew members; military personnel scheduled for training on extended air missions; and individuals who do not regularly use supplements containing taurine or stimulants
Exclusion criteria
Exclusion criteria: Individuals with medical or neurological conditions that may interfere with the perception of fatigue; regular users of stimulants or medications that affect sleep or cognition; pregnant or breastfeeding women; and participants with a history of adverse reactions or suspected hypersensitivity to taurine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Taurine supplementation is expected to improve performance due to increased alertness and reduced perception of fatigue. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
BR
Contacts
Public ContactGustavo Fanaro
Universidade do Estado do Rio de Janeiro
Outcome results
None listed